Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combinatorial libraries and biological discovery.

N S Gray1

  • 1Novartis Institute of Functional Genomics, 3115 Merryfield Row Suite 200, 92121-1125, San Diego, CA 92121-1125, USA. gray@gnf.org

Current Opinion in Neurobiology
|October 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.

Leukemia·2026
Same author

Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors.

Journal of biological regulators and homeostatic agents·2019
Same author

c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.

Oncogene·2016
Same author

Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway.

Leukemia·2016
Same author

ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT.

Oncogene·2015
Same author

Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.

Leukemia·2015
Same journal

On aims and methods in field neuroethology: Investigating neural mechanisms of behavior in semi-natural and natural contexts.

Current opinion in neurobiology·2026
Same journal

Neurobiological interfaces connecting environmental change to monarch butterfly migration.

Current opinion in neurobiology·2026
Same journal

Learning how to experience the world: From circuits to cell types to genes.

Current opinion in neurobiology·2026
Same journal

Editorial overview for neurobiology of disease 2026.

Current opinion in neurobiology·2026
Same journal

Optical voltage imaging: ready to spark systems neuroscience.

Current opinion in neurobiology·2026
Same journal

The neuroendocrine basis for parental care in teleost fish.

Current opinion in neurobiology·2026
See all related articles

Combinatorial chemistry prepares compound libraries to identify protein targets and inhibitors. These methods are crucial for discovering novel therapeutic compounds, particularly in neurological system research.

Area of Science:

  • Medicinal Chemistry
  • Chemical Biology
  • Neuroscience

Background:

  • Combinatorial chemistry is a widely used method for synthesizing compound libraries.
  • These libraries are essential for identifying biologically active molecules.
  • Protein targets are crucial in understanding and treating diseases.

Purpose of the Study:

  • To highlight the role of combinatorial chemistry in drug discovery.
  • To explain the integration of various techniques for target identification.
  • To emphasize applications in the neurological system.

Main Methods:

  • Combinatorial chemistry for compound library synthesis.
  • Affinity chromatography for target isolation.
  • Gene expression profiling for biological response analysis.

Related Experiment Videos

  • Complementation assays for functional validation.

    • Main Results:

    • Successful preparation of diverse small molecule libraries.
    • Identification of specific compounds and their corresponding protein targets.
    • Demonstration of applicability in complex biological systems.
    • Potential for discovering neurological system modulators.

    Conclusions:

    • Combinatorial chemistry is a powerful tool for discovering small molecule inhibitors and substrates.
    • Integrated approaches enhance the identification of compound-target interactions.
    • This methodology holds significant promise for advancing neurological research and drug development.